Chembio Diagnostics, Inc.
CEMI · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 30.9% | 21.3% | -11.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 20.2% | 6.6% | 21.6% | 35% |
| EBITDA | -$0 | -$0 | -$0 | -$1 |
| % Margin | -30.2% | -57.1% | -63.2% | -2,498.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -48.2% | -91.8% | -83.8% | -39.7% |
| EPS Diluted | -0.96 | -1.4 | -1.34 | -0.81 |
| % Growth | 31.4% | -4.5% | -65.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |